Proprietary AI analyst is now available

OrganoClick Valuation Multiples

Discover revenue and EBITDA valuation multiples for OrganoClick and similar public comparables like Svenska Aerogel, XP Chemistries, Eko Export, Cyclezyme and more.

OrganoClick Overview

About OrganoClick

OrganoClick AB is involved in the chemicals industry. Its product portfolio includes green chemical technologies for creating water repellency, biobased binders for increasing the mechanical strength, and wood treatment products for resistance to fungal degradation and resistance to fire. It operates in four business areas Functional Wood, Green coatings & maintenance products, Nonwoven & technical textile, and Other. The group has a single operating segment.


Founded

2006

HQ

Sweden

Employees

40

Sectors

Financials (FY)

Revenue: $11M
EBITDA: ($1M)

EV

$13M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

OrganoClick Financials

OrganoClick reported last fiscal year revenue of $11M and negative EBITDA of ($1M).

In the same fiscal year, OrganoClick generated $2M in gross profit, ($1M) in EBITDA losses, and had net loss of ($4M).

Revenue (LTM)


OrganoClick P&L

In the most recent fiscal year, OrganoClick reported revenue of $11M and EBITDA of ($1M).

OrganoClick is unprofitable as of last fiscal year, with gross margin of 14%, EBITDA margin of (12%), and net margin of (34%).

See analyst estimates for OrganoClick
Last FY202320242025202620272028
Revenue$11M$16M$14M$11M
Gross Profit$2M$4M$3M$2M
Gross Margin14%24%25%14%
EBITDA($1M)$634K$608K($1M)
EBITDA Margin(12%)4%4%(12%)
EBIT Margin(29%)(8%)(8%)(29%)
Net Profit($4M)($2M)($2M)($4M)
Net Margin(34%)(11%)(14%)(34%)
Net Debt$6M---

Financial data powered by Morningstar, Inc.

OrganoClick Stock Performance

OrganoClick has current market cap of $5M, and enterprise value of $13M.

Market Cap Evolution


OrganoClick's stock price is $0.05.

OrganoClick share price decreased by 11.6% in the last 30 days, and by 76.0% in the last year.

OrganoClick has an EPS (earnings per share) of $-0.04.

See more trading valuation data for OrganoClick
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$13M$5M-6.0%-11.6%-64.7%-76.0%$-0.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

OrganoClick Valuation Multiples

OrganoClick trades at 1.2x EV/Revenue multiple, and (9.7x) EV/EBITDA.

See NTM and 2027E valuation multiples for OrganoClick

EV / Revenue (LTM)


OrganoClick Financial Valuation Multiples

As of June 5, 2026, OrganoClick has market cap of $5M and EV of $13M.

OrganoClick has a P/E ratio of (1.4x).

Last FY202320242025202620272028
EV/Revenue1.2x0.9x1.0x1.2x
EV/EBITDA(9.7x)20.9x21.8x(9.7x)
EV/EBIT(4.0x)(10.6x)(11.8x)(4.0x)
EV/Gross Profit8.4x3.5x3.9x8.4x
P/E(1.4x)(3.2x)(2.8x)(1.4x)
EV/FCF(6.4x)(15.4x)(22.5x)(6.4x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified OrganoClick Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

OrganoClick Margins & Growth Rates

In the most recent fiscal year, OrganoClick reported gross margin of 14%, EBITDA margin of (12%), and net margin of (34%).

See estimated margins and future growth rates for OrganoClick

OrganoClick Margins

Last FY20242025202720282029
Gross Margin14%25%14%
EBITDA Margin(12%)4%(12%)
EBIT Margin(29%)(8%)(29%)
Net Margin(34%)(14%)(34%)
FCF Margin(18%)(4%)(18%)

OrganoClick Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(13%)(17%)
Gross Profit Growth(10%)(53%)
EBITDA Growth(4%)(325%)
EBIT Growth(10%)194%
Net Profit Growth14%102%
FCF Growth(32%)250%

Data powered by FactSet, Inc. and Morningstar, Inc.

OrganoClick Operational KPIs

OrganoClick's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Access forward-looking KPIs for OrganoClick
Last FY202320242025202620272028
Revenue per Employee$0.3M---
Opex per Employee$0.1M---
S&M Expenses to Revenue24%16%17%24%
G&A Expenses to Revenue14%9%12%14%
R&D Expenses to Revenue6%5%5%6%
Opex to Revenue43%32%33%43%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

OrganoClick Competitors

OrganoClick competitors include Svenska Aerogel, XP Chemistries, Eko Export, Cyclezyme, Australian Silica Quartz, Sinteza, EcoRub, Trinseo, Vystar and POLYDUCT Plastic.

Most OrganoClick public comparables operate across Chemicals.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Svenska Aerogel10.6x-(2.1x)-
XP Chemistries84.1x14.3x(4.5x)(4.7x)
Eko Export3.3x-(16.1x)-
Cyclezyme48.5x-(27.5x)-
Australian Silica Quartz----
Sinteza90.1x-144.9x-
EcoRub3.4x-(6.8x)-
Trinseo-0.9x-16.8x

This data is available for Pro users. Sign up to see all OrganoClick competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About OrganoClick

When was OrganoClick founded?OrganoClick was founded in 2006.
Where is OrganoClick headquartered?OrganoClick is headquartered in Sweden.
How many employees does OrganoClick have?As of today, OrganoClick has over 40 employees.
Is OrganoClick publicly listed?Yes, OrganoClick is a public company listed on Nasdaq Stockholm.
What is the stock symbol of OrganoClick?OrganoClick trades under ORGC ticker.
When did OrganoClick go public?OrganoClick went public in 2015.
Who are competitors of OrganoClick?OrganoClick main competitors include Svenska Aerogel, XP Chemistries, Eko Export, Cyclezyme, Australian Silica Quartz, Sinteza, EcoRub, Trinseo, Vystar, POLYDUCT Plastic.
What is the current market cap of OrganoClick?OrganoClick's current market cap is $5M.
What is the current revenue of OrganoClick?OrganoClick's last fiscal year revenue is $11M.
What is the current EV/Revenue multiple of OrganoClick?Current revenue multiple of OrganoClick is 1.2x.
Is OrganoClick profitable?No, OrganoClick is not profitable.
How many companies OrganoClick has acquired to date?OrganoClick hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies OrganoClick has invested to date?OrganoClick hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to OrganoClick

Lists including OrganoClick

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial